Suppr超能文献

钐 - 145:一种新型近距离放射治疗源。

Samarium-145: a new brachytherapy source.

作者信息

Fairchild R G, Kalef-Ezra J, Packer S, Wielopolski L, Laster B H, Robertson J S, Mausner L, Kanellitsas C

出版信息

Phys Med Biol. 1987 Jul;32(7):847-58. doi: 10.1088/0031-9155/32/7/005.

Abstract

A new radiation source has been produced for brachytherapy, with radiation energies slightly above those of 125I, and a T1/2 of 340 d. This source, 145Sm, is produced by neutron irradiation of 144Sm (96.5% enriched). Decay is by electron capture with 140 K x-rays per 100 disintegrations in the energy region between 38-45 keV, plus 13 gamma-rays at 61 keV. These sources are encapsulated in Ti tubes, approximately 0.8 mm X 4.5 mm, and have been developed for temporary implantation in brain and ocular tumours. The 38-61 keV photons should make such sources easy to shield, while providing a dose distribution from source arrays somewhat more homogeneous than that from 125I. In addition, the 340 d half life of 145Sm permits its use for times significantly longer than that of 60 d 125I. While the 145Sm sources have been designed primarily for implantation in a brain tumour, they should be useful for almost any conventional brachytherapy application.

摘要

一种用于近距离放射治疗的新型辐射源已被研制出来,其辐射能量略高于¹²⁵I,半衰期为340天。这种源¹⁴⁵Sm是通过对¹⁴⁴Sm(富集度为96.5%)进行中子辐照产生的。衰变通过电子俘获进行,每100次衰变在38 - 45 keV能量区域产生¹⁴⁰K x射线,外加61 keV的13条γ射线。这些源被封装在钛管中,钛管尺寸约为0.8毫米×4.5毫米,已被开发用于临时植入脑肿瘤和眼肿瘤。38 - 61 keV的光子应使此类源易于屏蔽,同时与¹²⁵I源阵列相比,能提供更均匀的剂量分布。此外,¹⁴⁵Sm的340天半衰期使其使用时间明显长于60天的¹²⁵I。虽然¹⁴⁵Sm源主要设计用于植入脑肿瘤,但它们几乎可用于任何传统的近距离放射治疗应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验